Blood clotting disorders in dogs: symptoms and treatment

Overview

Normal clotting starts with blood vessel constriction, reducing flow at the injury. Platelets adhere to damaged vessel walls and each other, forming an initial plug. Clotting proteins create a fibrin network that strengthens the plug and traps blood cells. Once stable, other proteins stop clotting and eventually begin breaking down the clot.

A disorder may involve too few platelets, poorly functioning platelets or inadequate clotting protein activity. Conversely, uncontrolled clotting can obstruct vessels and impair organ circulation. The type determines whether care aims to stop bleeding or prevent clots.

Causes

Abnormal platelet numbers or function

Thrombocytopenia develops when too few platelets are produced or too many are destroyed or consumed. In immune-mediated thrombocytopenia, the immune system destroys the dog's own platelets. Sometimes it also attacks platelet-producing cells in bone marrow.

An infection, medicine, tumour or inflammatory disease can underlie this reaction. If no trigger is found, the condition is called primary. Bone marrow diseases can also reduce platelet production. Bleeding can occur with a normal platelet count if function is poor.

Inherited deficiency, liver disease or poisoning

In von Willebrand disease, the vWF protein needed for clotting is deficient or functions poorly. Haemophilia A results from factor VIII deficiency. Haemophilia B results from factor IX deficiency. Severe liver disease can reduce production of several clotting proteins because most are made in the liver.

Anticoagulant rodent poisons prevent activation of vitamin K-dependent clotting factors. An exposed dog often does not bleed during the first 24 hours. Long-acting rodent poison can impair clotting factors for 2–4 weeks, and short-acting poison for 7–10 days. Fat malabsorption can also cause vitamin K deficiency and clotting problems. Conditions reducing vitamin K absorption include obstructed bile flow and severe intestinal malabsorption.

Risk factors

Severe inherited factor deficiencies often cause signs before 6 months of age. Haemophilia carriers are usually female, while affected patients are generally male. Middle-aged females, particularly Cocker Spaniels, are overrepresented in immune-mediated thrombocytopenia.

Breeds predisposed to type 1 von Willebrand disease include Dobermanns and Bernese Mountain Dogs. Type 3 is recognised in breeds including Kooikerhondjes, Scottish Terriers and Shetland Sheepdogs. Kidney and adrenal diseases and cancer can instead predispose to thrombosis. Mild inherited bleeding tendency may first appear after injury or surgery.

Typical symptoms

Platelet problems often cause small bleeds in skin or mucous membranes. Clotting factor deficiencies can instead cause deep haematomas or delayed bleeding.

• Tiny red-purple pinpoint haemorrhages appear on gums or skin.
• Bruises develop more easily.
• The nose or gums bleed.
• Urine may become bloody.
• Intestinal bleeding may cause black, tarry stools.
• An injection site or surgical wound bleeds longer than expected.
• Joint bleeding can cause lameness.

Blood loss may also cause weakness, pallor and faster breathing. Some dogs nevertheless have no symptoms despite very low platelet counts. Internal bleeding may become apparent only when the dog's condition collapses.

Complications and consequences

Blood loss, thrombosis and DIC

Heavy blood loss can cause anaemia, a shortage of red blood cells. With severe clotting disorders, surgery or a minor injury can cause life-threatening bleeding. A clot can obstruct a vessel and impair the organ supplied by it.

Disseminated intravascular coagulation, or DIC, can develop after conditions such as sepsis, heatstroke or severe injury. Initially, excessive small clots form and consume platelets and clotting factors. Later, the same patient may bleed severely because these are depleted.

Outlook varies with the cause

Von Willebrand disease has no cure. Nevertheless, many affected dogs can have a normal lifespan with appropriate care. In severe inherited factor deficiencies, activity below 1% can cause fatal bleeding at birth. With haemophilia A factor activity of 5–10%, a dog may avoid spontaneous bleeding but bleed longer after injury or surgery. Immune-mediated thrombocytopenia can recur during treatment or medication reduction. In DIC, the early hypercoagulable phase has a better outlook than the established severe bleeding phase.

Diagnosis at the vet

Platelets and clotting times are assessed separately

A blood count measures platelets and assesses possible anaemia. An automated low count can also be an error, so the result is verified.

Cavalier King Charles Spaniels can have a benign inherited large-platelet trait. This is estimated to affect about 30–50% of the breed. Its associated low count generally needs no treatment without bleeding signs.

Spontaneous bleeding risk increases particularly below about 30,000 platelets/µl. With isolated thrombocytopenia, procedure-related bleeding occurs particularly below 50,000/µl. If bleeding occurs at higher counts, other concurrent clotting abnormalities are investigated. A normal count does not exclude platelet dysfunction.

PT and aPTT are blood tests assessing clotting factor function. With anticoagulant rodent poison, PT often changes before other clotting tests. In liver disease, a result may be abnormal without directly predicting bleeding severity.

Further tests follow the suspected cause

Immune-mediated thrombocytopenia is generally diagnosed by excluding other causes of genuine low counts. Platelet antibody testing does not reliably settle the diagnosis. Bone marrow sampling is rarely needed for this investigation.

Von Willebrand disease testing measures blood vWF levels. Some breeds also have genetic tests for a specific form. A Kooikerhondje test must identify that breed's own type 3 variant. Normal PT and aPTT do not exclude von Willebrand disease.

X-rays and ultrasound may investigate internal bleeding or underlying disease. A predisposing condition and at least 3 abnormal clotting parameters support DIC. Viscoelastic testing measures whole-clot formation and strength, helping distinguish excessive from inadequate clotting.

Treatment

Stabilising a bleeding patient and replacing missing components

Your vet chooses treatment according to bleeding severity and the identified disorder. Acute heavy blood loss may require transfusion for stabilisation. Red blood cell products correct symptomatic anaemia. Plasma can replace missing clotting factors.

Severe von Willebrand bleeding may be treated with plasma or cryoprecipitate, a concentrated blood product. Desmopressin can improve bleeding control in mild type 1 disease. It is not used to treat type 3 von Willebrand disease. Haemophilia bleeding may need repeated plasma product transfusions until controlled.

Immune-mediated disease and poisoning need different treatment

In immune-mediated thrombocytopenia, medication suppresses the attack on the dog's own platelets. Initial medicines often include glucocorticoids. Severe or recurrent cases may need other immunosuppressive medicines too. Medication reduction and associated platelet monitoring can be prolonged.

Platelet transfusion may help life-threatening bleeding even without normalising the count. Spleen removal is considered only for recurrent or poorly responsive cases.

Prescribed vitamin K1 treats the disorder caused by anticoagulant rodent poison. A severely bleeding poisoned patient may also need blood products. PT is usually rechecked 48 hours after the initial treatment course ends. The result determines whether treatment has been sufficient.

Thrombosis and DIC need treatment of the underlying disease

In thrombosis, care treats the cause and maintains tissue circulation. Your vet may select medication to prevent new clots or help dissolve them. Identifying and treating the triggering disease is the priority in DIC. Anticoagulant treatment may be used in its excessive-clotting phase.

When a DIC patient bleeds severely, care shifts towards measures such as plasma replacement of clotting factors. Fluids may help maintain adequate circulating volume. Repeated platelet and clotting tests monitor effectiveness.

Prevention

Breed-appropriate examinations and genetic tests guide breeding to prevent inherited bleeding tendencies. Some Kooikerhondje breeding guidelines require vWD status to be established through the dog's own or ancestors' genetic tests. A type 1 von Willebrand genetic test is available for Dobermanns.

A dog with abnormal bleeding should not be bred. Mating two carriers of the same severe vWD form is avoided because of affected puppy risk. Known bleeding tendency is considered before planned surgery. Medicines impairing clotting or platelet function are avoided in dogs with bleeding disorders.

Important for dog owners

Keep a bleeding dog calm and avoid situations risking further injury. Monitor gums, skin, stools and urine for new bleeding. Record onset and previous problems after surgery or injections.

Mention a diagnosed bleeding disorder before dentistry or another procedure. Bring details of current medicines. Include genetic test results in care planning too.

Absence of symptoms does not establish that platelet counts or clotting have normalised. Scheduled blood checks are therefore needed even if your dog appears recovered.

Frequently asked questions

Can my dog have a clotting disorder with a normal platelet count?

Counts can be normal despite poor platelet function. Clotting protein deficiency can also cause bleeding. Clotting times and von Willebrand factor testing may therefore be needed alongside platelet counting. PT and aPTT can also be normal in von Willebrand disease.

Do bruises and nosebleeds always indicate poisoning?

They can occur with immune-mediated thrombocytopenia, for example. Von Willebrand disease can cause similar bleeding. Rodent poison is one possibility, but blood tests and other investigations distinguish causes. In some patients, bleeding becomes apparent only after injury or surgery.

What platelet count is dangerous?

Spontaneous bleeding risk usually increases below about 30,000/µl. Some dogs may nevertheless show no outward symptoms. With other clotting abnormalities, bleeding may occur at higher counts and need further investigation.

Does vitamin K treat every canine bleeding disorder?

Vitamin K1 treats anticoagulant rodent poison-related disorders. Immune-mediated thrombocytopenia instead needs immune-directed treatment. Severe von Willebrand bleeding often requires blood products, so treatment must match the actual cause.

Can a dog with an inherited bleeding disorder live normally?

Many dogs with von Willebrand disease can have a normal lifespan with appropriate care. However, the outlook depends on its form and associated bleeding risk. Planned procedures are prepared for in advance, including necessary blood products. Medicines worsening bleeding tendency are avoided.